Literature DB >> 11265778

Tumor-dendritic cell fusion technology and immunotherapy strategies.

S Shu1, P Cohen.   

Abstract

Mesh：

Year:  2001        PMID： 11265778

Source DB:  PubMed          Journal:  J Immunother        ISSN： 1524-9557            Impact factor:   4.456


× No keyword cloud information.
  4 in total

1.  Collagen I enhances the efficiency and anti-tumor activity of dendritic-tumor fusion cells.

Authors:  Jian He; Rong Zheng; Zhenghua Zhang; Jie Tan; Chaofan Zhou; Guoqing Zhang; Xinglu Jiang; Qianyi Sun; Sufang Zhou; Duo Zheng; Yong Huang; Lige Wu; Zongqiang Lai; Jieping Li; Nuo Yang; Xiaoling Lu; Yongxiang Zhao
Journal:  Oncoimmunology       Date:  2017-08-08       Impact factor: 8.110

2.  Enhanced stimulation of anti-ovarian cancer CD8(+) T cells by dendritic cells loaded with nanoparticle encapsulated tumor antigen.

Authors:  Douglas J Hanlon; Paulomi B Aldo; Lesley Devine; Ayesha B Alvero; Anna K Engberg; Richard Edelson; Gil Mor
Journal:  Am J Reprod Immunol       Date:  2011-01-18       Impact factor: 3.886

3.  Paired Toll-like receptor agonists enhance vaccine therapy through induction of interleukin-12.

Authors:  Rongxiu Zheng; Peter A Cohen; Christopher A Paustian; Terrence D Johnson; Walter T Lee; Suyu Shu; Gary K Koski
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

4.  In vitro antitumor immune response induced by fusion of dendritic cells and colon cancer cells.

Authors:  Feng Xu; Ying-Jiang Ye; Shan Wang
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.